SELECTIVE NEURONAL VULNERABILITY IN SPORADIC ALS
SELECTIVE NEURONAL VULNERABILITY IN SPORADIC ALS
批准号:
2271818
负责人:
Stanley H. Appel
金额:
$24.51万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-08-01 至 1998-07-31
关键词:
amyotrophic lateral sclerosis antibody calbindin calcium calcium binding protein calcium channel calcium flux calcium metabolism cell death cellular pathology confocal scanning microscopy cytotoxicity enzyme linked immunosorbent assay homeostasis human tissue immunoglobulin G intracellular motor neurons neuropharmacology protein structure tissue /cell culture transfection voltage gated channel western blottings
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The neurodegenerative diseases including amyotrophic lateral sclerosis
(ALS) are devastating idiopathic clinical disorders
that result in selective neuronal injury and death. Our general
hypothesis is that increased intracellular calcium, produced by active
calcium influx across the plasmalemma or release of calcium from
intracellular stores, and/or limited calcium buffering capacity, is
critically important in neurodegenerative cell injury. Factors dictating
selective vulnerability in these diseases may include alterations in any
of these processes, likely coupled with selective sensitivity to altered
calcium homeostasis. Our own studies of sporadic neurodegenerative
disease have documented the presence of antibodies to voltage-gated
calcium channels (VGCCs) in sporadic but not familial ALS. ALS IgG
produce different electrophysiologically assayed effects on different
VGCC types, inhibiting calcium current when added to skeletal muscle L-
type VGCCs, while enhancing calcium current, increasing intracellular
calcium, and causing cell death when added to neuronal VGCCs in motor
neuron cell lines.
The motor neuron cell line (VSC 4.1), developed in our laboratory by
fusion or murine N18TG2 neuroblastoma line and dissociated embryonic rat
ventral spinal cord, expresses biochemical and morphological motor neuron
markers as well as neuronal VGCCs when differentiated in the presence of
cAMP and aphidocolin. After ALS IgG addition in vitro, there is a marked
enhancement of calcium current in differentiated cells (not noted with
disease control IgG). Using calcium imaging techniques, ALS IgG also
induces a marked, prolonged increase in intracellular calcium, which is
followed by VSC 4.1 cell death after twenty-four to seventy-two hours.
This cell system will allow us to define ALS IgG-dependent mechanisms
permitting prolonged increases in intracellular calcium. We plan to
define the relationship in detail between the increased intracellular
calcium and the subsequent cell death. Furthermore, since VSC 4.1 cells
demonstrate decreased immunohistochemically recognized calbindin D28K and
parvalbumin levels during differentiation (concomitant with onset of
vulnerability to ALS IgG), a detailed evaluation will be undertaken of
the potential role of these calcium binding proteins in selective
vulnerability.
These studies should aid in understanding the roles played by increased
intracellular calcium and altered calcium buffering on selective neuronal
vulnerability in sporadic ALS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Blocking TLR-Activation of Regulatory T cells Slows Disease in ALS
-
批准号:8491387
-
项目类别:
-
资助金额:$19.69万
-
财政年份:2013
-
负责人:Stanley H. Appel
-
依托单位:
Blocking TLR-Activation of Regulatory T cells Slows Disease in ALS
-
批准号:8635400
-
项目类别:
-
资助金额:$23.39万
-
财政年份:2013
-
负责人:Stanley H. Appel
-
依托单位:
CLINICAL TRIAL: PHASE I/II TRIAL USING CYCLOPHOSPHAMIDE AND LOW-DOSE IL-2 TO IN
-
批准号:8356778
-
项目类别:
-
资助金额:$3.13万
-
财政年份:2010
-
负责人:Stanley H. Appel
-
依托单位:
Using CD4+ T cells as a candidate therapy to slow disease progression in ALS
-
批准号:8022831
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2010
-
负责人:Stanley H. Appel
-
依托单位:
Using CD4+ T cells as a candidate therapy to slow disease progression in ALS
-
批准号:7774428
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2010
-
负责人:Stanley H. Appel
-
依托单位:
CLINICAL TRIAL: PHASE I/II TRIAL USING CYCLOPHOSPHAMIDE AND LOW-DOSE IL-2 TO IND
-
批准号:8166775
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2009
-
负责人:Stanley H. Appel
-
依托单位:
The Role of Microglia in Models of ALS
-
批准号:7117593
-
项目类别:
-
资助金额:$29.27万
-
财政年份:2004
-
负责人:Stanley H. Appel
-
依托单位:
The Role of Microglia in Models of ALS
-
批准号:7247115
-
项目类别:
-
资助金额:$28.42万
-
财政年份:2004
-
负责人:Stanley H. Appel
-
依托单位:
The Role of Microglia in Models of ALS
-
批准号:6808484
-
项目类别:
-
资助金额:$31.32万
-
财政年份:2004
-
负责人:Stanley H. Appel
-
依托单位:
The Role of Microglia in Models of ALS
-
批准号:6898178
-
项目类别:
-
资助金额:$30.07万
-
财政年份:2004
-
负责人:Stanley H. Appel
-
依托单位:
SELECTIVE VULNERABILITY OF SPORADIC NEURODEGENERATIVE DISEASE
-
批准号:6318257
-
项目类别:
-
资助金额:$7.96万
-
财政年份:2000
-
负责人:Stanley H. Appel
-
依托单位:
SELECTIVE VULNERABILITY OF SPORADIC NEURODEGENERATIVE DISEASE
-
批准号:6218712
-
项目类别:
-
资助金额:$7.96万
-
财政年份:1999
-
负责人:Stanley H. Appel
-
依托单位:
SELECTIVE VULNERABILITY OF SPORADIC NEURODEGENERATIVE DISEASE
-
批准号:6098188
-
项目类别:
-
资助金额:$7.96万
-
财政年份:1999
-
负责人:Stanley H. Appel
-
依托单位:
SELECTIVE VULNERABILITY OF SPORADIC NEURODEGENERATIVE DISEASE
-
批准号:6295500
-
项目类别:
-
资助金额:$7.96万
-
财政年份:1999
-
负责人:Stanley H. Appel
-
依托单位:
SELECTIVE VULNERABILITY OF SPORADIC NEURODEGENERATIVE DISEASE
-
批准号:6295508
-
项目类别:
-
资助金额:$7.96万
-
财政年份:1998
-
负责人:Stanley H. Appel
-
依托单位:
SELECTIVE VULNERABILITY OF SPORADIC NEURODEGENERATIVE DISEASE
-
批准号:6267426
-
项目类别:
-
资助金额:$12.66万
-
财政年份:1998
-
负责人:Stanley H. Appel
-
依托单位:
SELECTIVE VULNERABILITY OF SPORADIC NEURODEGENERATIVE DISEASE
-
批准号:6234197
-
项目类别:
-
资助金额:$11.97万
-
财政年份:1997
-
负责人:Stanley H. Appel
-
依托单位:
ALS IGG EFFECTS ON MOTORNEURON UNTRASTRUCTURE
-
批准号:2416484
-
项目类别:
-
资助金额:$2.59万
-
财政年份:1996
-
负责人:Stanley H. Appel
-
依托单位:
ALS IGG EFFECTS ON MOTORNEURON UNTRASTRUCTURE
-
批准号:2292257
-
项目类别:
-
资助金额:$2.58万
-
财政年份:1996
-
负责人:Stanley H. Appel
-
依托单位:
ALS IGG EFFECTS ON MOTORNEURON UNTRASTRUCTURE
-
批准号:2703206
-
项目类别:
-
资助金额:$2.58万
-
财政年份:1996
-
负责人:Stanley H. Appel
-
依托单位:
海外基金